Cold urticaria with risk of anaphylaxis treated with omalizumab: a case report. Revista Alergia México, [S. l.], v. 67, n. 4, p. 408–412, 2021. DOI: 10.29262/ram.v67i4.744. Disponível em: https://ojs.revistaalergia.mx/ojs/index.php/ram/article/view/744. Acesso em: 23 sep. 2026.